InSilicoTrials Appoints Mark Lovern as Chief Platform Officer


Move marks commitment to leading the frontier of AI-driven innovation and simulation in life sciences, company says.

Businessman holding building of real estate icons.Generative AI. Image Credit: Adobe Stock Images/minati

Image Credit: Adobe Stock Images/minati

InSilicoTrials revealed that it has officially hired Mark Lovern to be its new chief platform officer. In his new role, Lovern will focus on combining his scientific knowledge with artificial intelligence (AI), machine learning (ML) and simulation technologies, along with an in-depth understanding of regulatory science, to drive the development of the platform and position it as a catalyst for hyper-accelerating life science R&D.

"Mark's extensive experience and mastery in model-informed drug development align seamlessly with our vision of revolutionizing the life sciences industry," said Luca Emili, CEO, InSilicoTrials, in a company press release. "His prior achievements, combined with our groundbreaking AI and simulations platform, will surely take our capabilities to unprecedented heights.”

Reference: Mark Lovern Joins InSilicoTrials as Chief Platform Officer. PR Newswire. October 17, 2023. Accessed October 19, 2023.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Cat Hall endpoint Clinical
OM1 Sonja Wustrack
© 2023 MJH Life Sciences

All rights reserved.